Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Biol Chem ; 295(9): 2866-2884, 2020 02 28.
Article in English | MEDLINE | ID: mdl-31959628

ABSTRACT

Aberrant Ras signaling drives 30% of cancers, and inhibition of the Rho family small GTPase signaling has been shown to combat Ras-driven cancers. Here, we present the discovery of a 16-mer cyclic peptide that binds to Cdc42 with nanomolar affinity. Affinity maturation of this sequence has produced a panel of derived candidates with increased affinity and modulated specificity for other closely-related small GTPases. The structure of the tightest binding peptide was solved by NMR, and its binding site on Cdc42 was determined. Addition of a cell-penetrating sequence allowed the peptides to access the cell interior and engage with their target(s), modulating signaling pathways. In Ras-driven cancer cell models, the peptides have an inhibitory effect on proliferation and show suppression of both invasion and motility. As such, they represent promising candidates for Rho-family small GTPase inhibitors and therapeutics targeting Ras-driven cancers. Our data add to the growing literature demonstrating that peptides are establishing their place in the biologics arm of drug discovery.


Subject(s)
Drug Discovery , Peptides, Cyclic/pharmacology , Signal Transduction/drug effects , cdc42 GTP-Binding Protein/antagonists & inhibitors , ras Proteins/metabolism , Binding Sites , Cell Movement/drug effects , Cell Proliferation/drug effects , Cell-Penetrating Peptides , GTP Phosphohydrolases/antagonists & inhibitors , Humans , Molecular Structure , Neoplasm Invasiveness/prevention & control , Neoplasms/drug therapy , Peptides, Cyclic/chemistry , Peptides, Cyclic/metabolism , cdc42 GTP-Binding Protein/metabolism
2.
J Biol Chem ; 292(27): 11361-11373, 2017 07 07.
Article in English | MEDLINE | ID: mdl-28539360

ABSTRACT

Cdc42 is a Rho-family small G protein that has been widely studied for its role in controlling the actin cytoskeleton and plays a part in several potentially oncogenic signaling networks. Similar to most other small G proteins, Cdc42 binds to many downstream effector proteins to elicit its cellular effects. These effector proteins all engage the same face of Cdc42, the conformation of which is governed by the activation state of the G protein. Previously, the importance of individual residues in conferring binding affinity has been explored for residues within Cdc42 for three of its Cdc42/Rac interactive binding (CRIB) effectors, activated Cdc42 kinase (ACK), p21-activated kinase (PAK), and Wiskott-Aldrich syndrome protein (WASP). Here, in a complementary study, we have used our structure of Cdc42 bound to ACK via an intrinsically disordered ACK region to guide an analysis of the Cdc42 interface on ACK, creating a panel of mutant proteins with which we can now describe the complete energetic landscape of the Cdc42-binding site on ACK. Our data suggest that the binding affinity of ACK relies on several conserved residues that are critical for stabilizing the quaternary structure. These residues are centered on the CRIB region, with the complete binding region anchored at each end by hydrophobic interactions. These findings suggest that ACK adopts a dock and coalesce binding mechanism with Cdc42. In contrast to other CRIB-family effectors and indeed other intrinsically disordered proteins, hydrophobic residues likely drive Cdc42-ACK binding.


Subject(s)
Protein-Tyrosine Kinases/chemistry , cdc42 GTP-Binding Protein/chemistry , Binding Sites , Humans , Mutation , Protein Binding , Protein Structure, Quaternary , Protein-Tyrosine Kinases/genetics , Protein-Tyrosine Kinases/metabolism , cdc42 GTP-Binding Protein/genetics , cdc42 GTP-Binding Protein/metabolism
3.
Brief Funct Genomics ; 10(3): 125-34, 2011 May.
Article in English | MEDLINE | ID: mdl-21628313

ABSTRACT

The presentation of recombinant peptide libraries linked to their coding sequence can be referred to as 'peptide display'. Phage display is the most widely practiced peptide display technology but more recent alternatives such as CIS display, ribosome display and mRNA display offer advantages over phage for speed, library size and the display of unnatural amino acids. These have provided researchers with tools to address some of the failings of peptides such as their low affinity, low stability and inability to cross biological membranes. In this review, we assess some of the recent advances in peptide display and its application.


Subject(s)
Peptide Library , Peptides/chemistry , Amino Acids/chemistry , Bacteriophages/metabolism , Models, Biological
4.
Protein Eng Des Sel ; 22(11): 691-8, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19755412

ABSTRACT

One drawback to the use of peptides as therapeutics has been their susceptibility to proteolysis. Here, we have used an in vitro display technology, CIS display, to enhance the proteolytic resistance of ligand-binding peptides by selection of protecting motifs from a large peptide library. The premise to this selection was that certain linear peptides within a library could form structures capable of preventing the access of proteases to defined cleavage sites without affecting ligand binding. A diverse 12-mer peptide library was inserted between a FLAG epitope motif and a thrombin cleavage site and this construct was fused to the bacterial initiator protein RepA for CIS display selection. After five rounds of selection, protection motifs were isolated that were capable of preventing proteolytic cleavage of the adjacent thrombin site. Some of the selected peptides were also resistant to more promiscuous proteases, such as chymotrypsin and trypsin, which were not used in the selection. The observed resistance to thrombin, trypsin and chymotrypsin translated into increased resistance to plasma proteases in vitro and to an increase in circulating half-lives in rats. This method can be applied to enhancing the in vivo stability of therapeutic peptides.


Subject(s)
Peptide Hydrolases/metabolism , Peptides/metabolism , Amino Acid Sequence , Animals , Female , Humans , Ligands , Molecular Sequence Data , Peptide Hydrolases/blood , Peptide Library , Peptides/analysis , Peptides/chemistry , Peptides/therapeutic use , Protein Stability , Rats , Thrombin/metabolism
5.
Mol Plant Microbe Interact ; 15(12): 1253-67, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12481998

ABSTRACT

The hydrophobin-encoding gene MPG1 of the rice blast fungus Magnaporthe grisea is highly expressed during the initial stages of host plant infection and targeted deletion of the gene results in a mutant strain that is reduced in virulence, conidiation, and appressorium formation. The green fluorescent protein-encoding allele sGFP was used as a reporter to investigate regulatory genes that control MPG1 expression. The MAP kinase-encoding gene PMK1 and the wide domain regulators of nitrogen source utilization, NPR1 and NUT1, were required for full expression of MPG1 in response to starvation stress. The CPKA gene, encoding the catalytic subunit of protein kinase A, was required for repression of MPG1 during growth in rich nutrient conditions. During appressorium morphogenesis, high-level MPG1 expression was found to require the CPKA and NPR1 genes. Expression of a destabilized GFP allele indicated that de novo MPG1 expression occurs during appressorium formation. Three regions of the MPG1 promoter were identified which are required for high-level expression of MPG1 during appressorium formation and are necessary for the biological activity of the MPG1 hydrophobin during spore formation and plant infection.


Subject(s)
Fungal Proteins/genetics , Gene Expression Regulation, Fungal , Magnaporthe/genetics , Oryza/microbiology , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Fungal Proteins/metabolism , Green Fluorescent Proteins , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Magnaporthe/growth & development , Magnaporthe/ultrastructure , Microscopy, Electron , Microscopy, Fluorescence , Mitogen-Activated Protein Kinases/genetics , Mitogen-Activated Protein Kinases/metabolism , Mutation , Plant Diseases/microbiology , Promoter Regions, Genetic/genetics , Protein Kinases/genetics , Protein Kinases/metabolism , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Saccharomyces cerevisiae Proteins/genetics , Saccharomyces cerevisiae Proteins/metabolism , Spores, Fungal/genetics , Spores, Fungal/growth & development , Spores, Fungal/ultrastructure
SELECTION OF CITATIONS
SEARCH DETAIL
...